Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Journey Medical (DERM) Change in Accured Expenses: 2020-2024

Historic Change in Accured Expenses for Journey Medical (DERM) over the last 5 years, with Dec 2024 value amounting to -$2.9 million.

  • Journey Medical's Change in Accured Expenses fell 3883.33% to -$1.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.2 million, marking a year-over-year increase of 28944.44%. This contributed to the annual value of -$2.9 million for FY2024, which is 404.05% down from last year.
  • Per Journey Medical's latest filing, its Change in Accured Expenses stood at -$2.9 million for FY2024, which was down 404.05% from $962,000 recorded in FY2023.
  • Journey Medical's 5-year Change in Accured Expenses high stood at $2.4 million for FY2020, and its period low was -$3.6 million during FY2022.
  • Its 3-year average for Change in Accured Expenses is -$1.8 million, with a median of -$2.9 million in 2024.
  • In the last 5 years, Journey Medical's Change in Accured Expenses skyrocketed by 126.96% in 2023 and then crashed by 404.05% in 2024.
  • MRY analysis of 5 years shows Journey Medical's Change in Accured Expenses stood at $2.4 million in 2020, then crashed by 48.33% to $1.2 million in 2021, then plummeted by 388.91% to -$3.6 million in 2022, then soared by 126.96% to $962,000 in 2023, then tumbled by 404.05% to -$2.9 million in 2024.
  • Its last three reported values are -$2.9 million in FY2024, $962,000 for FY2023, and -$3.6 million during FY2022.